AIDS vaccine researchers and developers address the short supply of manufacturing and process development capacity

AIDS vaccine trial sponsors weigh the merits of intermediate-size efficacy trials

By Roberto Fernandez-Larsson, Ph.D.*

New light on how HIV is transmitted

University of Massachusetts Medical School begins clinical trial of multiclade AIDS vaccine

By Richard Jefferys*

The 11th Conference on Retroviruses and Opportunistic Infections took place from 8-11 February, drawing over 3,500 researchers and activists from around the world into the cavernous halls of San Francisco’s Moscone Convention Center.